- Report
- August 2024
- 102 Pages
Global
From €3500EUR$3,929USD£3,035GBP
The Angiopoietin 1 Receptor (ANGPT1) is a type of enzyme that plays a role in the regulation of vascular development and homeostasis. It is a member of the Tie family of receptor tyrosine kinases, which are involved in the regulation of angiogenesis, the formation of new blood vessels. ANGPT1 is expressed in endothelial cells, and its activation leads to the formation of new blood vessels. ANGPT1 is also involved in the regulation of inflammation, and its activation can lead to the production of pro-inflammatory cytokines.
The ANGPT1 receptor market is a rapidly growing field, with a number of companies developing products to target the receptor. Companies such as Novartis, Merck, and Pfizer are developing ANGPT1 inhibitors for the treatment of various diseases, including cancer and cardiovascular diseases. Other companies, such as Amgen and AstraZeneca, are developing ANGPT1 agonists for the treatment of inflammatory diseases. Show Less Read more